IMMUNOCORP CONSUMER HEALTH AS

1366 LYSAKER

Finances

Share Ownership

Return on Equity

28,69 %

Current Ratio

10,89

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	0	0	0	0
Net Income	863 000	837 000	−74 000	−17 793 000
Total Assets	3 036 000	2 296 000	1 431 000	6 002 000
Total Equity	3 008 000	2 145 000	1 426 000	1 172 000

Income (NOK)	2022	2021	2020	2019
Revenue	0	0	0	0
Expenditure	−88 000	72 000	50 000	7 913 000
Operating Profit	88 000	−72 000	−50 000	−7 913 000
Financial Income	775 000	942 000	0	1 025 000
Financial Costs	0	0	116 000	11 188 000
Financial Balance	775 000	942 000	−116 000	−10 163 000
Earnings Before Tax	863 000	870 000	−166 000	−18 076 000
Tax	0	33 000	−93 000	−282 000
Net Income	863 000	837 000	−74 000	−17 793 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	2 731 000	1 500 000	0	0
Total Current Assets	305 000	796 000	1 431 000	6 002 000
Total Assets	3 036 000	2 296 000	1 431 000	6 002 000
Total Retained Equity	1 582 000	718 000	0	0
Total Equity	3 008 000	2 145 000	1 426 000	1 172 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	28 000	152 000	5 000	4 830 000
Total Equity and Debt	3 036 000	2 296 000	1 431 000	6 002 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	0	0	0	0
Other Income	0	0	0	0
Revenue	0	0	0	0
Cost of Goods Sold	0	0	0	0
Salary Costs	0	0	0	0
Depreciation	0	0	0	0
Impairment	0	0	0	0
Expenditure	−88 000	72 000	50 000	7 913 000
Operating Profit	88 000	−72 000	−50 000	−7 913 000
Financial Income	775 000	942 000	0	1 025 000
Financial Costs	0	0	116 000	11 188 000
Financial Balance	775 000	942 000	−116 000	−10 163 000
Dividends	0	0	0	0
Net Income	863 000	837 000	−74 000	−17 793 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	0	0	0
Total Tangible Assets	0	0	0	0
Total Fiancial Fixed Assets	2 731 000	1 500 000	0	0
Total Fixed Assets	2 731 000	1 500 000	0	0
Stock	0	0	0	0
Total Investments	0	0	0	0
Cash, Bank	305 000	791 000	0	0
Total Current Assets	305 000	796 000	1 431 000	6 002 000
Total Assets	3 036 000	2 296 000	1 431 000	6 002 000
Total Equity	3 008 000	2 145 000	1 426 000	1 172 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	0	0	0
Creditors	28 000	0	0	2 000
Unpaid Taxes	0	0	0	0
Dividends	0	0	0	0
Other Current Debt	0	152 000	5 000	4 827 000
Total Current Debt	28 000	152 000	5 000	4 830 000
Total Equity and Debt	3 036 000	2 296 000	1 431 000	6 002 000

Financial indicators	2022	2021	2020	2019
Return on Equity	28,69 %	39,02 %	−5,19 %	−1 518,17 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	-	-	-	-
Current Ratio	10,89	5,24	286,2	1,24
Quick Ratio	10,89	5,24	286,2	1,24
Equity Ratio	0,99	0,93	1	0,2
Gross Profit Margin	-	-	-	-